China Adrenal Disease Registry
China Adrenal Disease Registry Study
Shanghai Jiao Tong University School of Medicine
2,000 participants
Jun 1, 2021
OBSERVATIONAL
Conditions
Summary
Epidemiologic studies have revealed a tremendous increase in the prevalence of adrenal associated disease and related mortality worldwide. In order to meet all the therapeutic challenges in adrenal disease in China, CASE was founded in 2020. The objective of CASE is to launch an adrenal disease management model based on the Internet health information platform which allows the application and evaluation of adrenal disease treatment strategies at multiple centers. The proprietary electronic medical database will help the dynamic big-data analysis in epidemiology of adrenal disease, diagnosis, and treatment.
Eligibility
Inclusion Criteria4
- Age ≥ 16 years old and ≤ 75 years
- Patients diagnosed with adrenal associated diseases, including cushing syndrome, primary aldosteronism, primary hypoadrenalism, congenital adrenal hyperplasia and adrenal adenomas, incidentalomas, and carcinomas, pheochromocytoma, etc.
- Provide written informed consent
- Satisfactory compliance
Exclusion Criteria3
- Patients with significantly reduced life expectancy (less than 2 years)
- With Drug abuse
- With AIDS or syphilis or infectious diseases such as viral tuberculosis in active phase at enrollment
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04890444